Close Menu
Daily Guardian
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Health
  • Sports
  • Technology
  • Climate
  • Auto
  • Travel
  • Web Stories
What's On

iPhone may be one factor in falling birth rates, researchers say

June 13, 2026

FREELANDER 8 Makes First Public Appearance Ahead of Official Abu Dhabi Launch

June 13, 2026

Hitch Open Ping-Pong Embodied (HOPE) AI Challenge Joins the 2026 World Humanoid Robot Games, Seeding Advanced Physical AI Against Human Performance

June 13, 2026

No Deposit Bonus Casino Real Money 2026 – BetOnline Offered No Deposit Bonuses

June 13, 2026

Rent Water Purifier in Chennai Instead of Buying in 2026: Rentomojo Highlights Rising AMC (Annual Maintenance Charges) Driving Shift to Rentals

June 12, 2026
Facebook X (Twitter) Instagram
Finance Pro
Facebook X (Twitter) Instagram
Daily Guardian
Subscribe
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Health
  • Sports
  • Technology
  • Climate
  • Auto
  • Travel
  • Web Stories
Daily Guardian
Home » New Study Finds Trimsulin Achieves 243% Greater Weight Loss than Semaglutide without Serious Side Effects
Press Release

New Study Finds Trimsulin Achieves 243% Greater Weight Loss than Semaglutide without Serious Side Effects

By News RoomOctober 24, 20242 Mins Read
New Study Finds Trimsulin Achieves 243% Greater Weight Loss than Semaglutide without Serious Side Effects
Share
Facebook Twitter LinkedIn Pinterest Email

FRISCO, Texas, Oct. 24, 2024 (GLOBE NEWSWIRE) — A new preprint study found the Trimsulin Weight Loss Program, a nutraceutical plant-based supplement, outperformed leading weight loss drugs, semaglutide, and tirzepatide. Overweight adults using Trimsulin experienced significantly more weight loss with fewer side effects.

The study monitored 503 FFN participants over six months, comparing orally ingested Trimsulin against injectable semaglutide and tirzepatide. The results were impressive: Trimsulin users lost 14.1% of their body weight, compared to 5.8% for semaglutide and 10.1% for tirzepatide. Trimsulin provided superior weight loss and minimal adverse effects, with only 4.8% of participants reporting mild side effects.

No serious side effects were reported by Trimsulin users, whereas 3% of semaglutide and 5-7% of tirzepatide patients reported issues such as pancreatitis, bowel obstructions, psychiatric problems, and cardiovascular disorders.

Dr. Richard Clark Kaufman, lead researcher, remarked, “Trimsulin is a game-changer. Its nutraceutical composition stimulates the body to naturally release GLP-1 and GIP hormones and inhibits the enzyme DPP-4 degrading them, offering a safe GLP-1 alternative. People can achieve their weight-loss goals without enduring the common side effects of semaglutide and tirzepatide.”

Key Findings:

  • Trimsulin users achieved 243% greater weight loss compared to semaglutide and 139% greater weight loss compared to tirzepatide.
  • Gastrointestinal adverse effects were dramatically lower: 4.8% for Trimsulin, compared to 59.7% for semaglutide and 46% for tirzepatide.
  • Plant-Based Nutraceutical Composition: Trimsulin’s plant-based nutraceutical composition supports safe, sustainable weight loss by naturally releasing GLP-1 and GIP.

Nigel Branson, President and Co-Founder of FirstFitness Nutrition, stated, “The Trimsulin Weight Loss Program is transforming lives nationwide with an affordable, plant-based GLP-1 solution without adverse effects.”

Trimsulin is taken as a drink mix and capsules. No prescription is needed! The program includes a healthy eating and lifestyle guide based on the Mediterranean diet, offering a long-term solution for weight loss without sacrificing muscle mass.

About Trimsulin:

Trimsulin is a patent-pending, plant-based nutraceutical weight loss program that promotes lasting weight loss by naturally boosting GLP-1 and GIP levels, inhibiting DPP-4 from degrading them, and regulating blood sugar. Thermogenic agents transform stored fat into energy, accelerating weight loss while keeping you energized.

To understand the science behind Trimsulin, read the complete study: Read the study.  

To learn more and experience Trimsulin: Try Trimsulin – Click Here.

Contact Information:
For inquiries, contact the FirstFitness Nutrition Media Team at: [email protected]

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/284e36e8-de4b-4596-8b80-73e0b979bc97

Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

Keep Reading

FREELANDER 8 Makes First Public Appearance Ahead of Official Abu Dhabi Launch

Hitch Open Ping-Pong Embodied (HOPE) AI Challenge Joins the 2026 World Humanoid Robot Games, Seeding Advanced Physical AI Against Human Performance

No Deposit Bonus Casino Real Money 2026 – BetOnline Offered No Deposit Bonuses

Rent Water Purifier in Chennai Instead of Buying in 2026: Rentomojo Highlights Rising AMC (Annual Maintenance Charges) Driving Shift to Rentals

Defiance ETFs Announces Temporary Trading Halt of the Defiance Daily 2X Space ETF (SPCL) on Cboe BZX Exchange, Inc.

Crypto News Today: AlphaPepe Unveils AlphaSwap Early Access as Bitcoin Price Prediction Eyes $250,000

Cushing crude stocks sit less than 2 mmbbls above operational floor amid global supply crisis

Rare Jewellery, Beads and Gemstones from Ancient Civilisations Headline Apollo Art Auctions’ June Jewellery Sale 

UPDATE – ITS Logistics June Port/Rail Ramp Freight Index: Drayage and Intermodal Markets Brace for Downstream Price Surges

Editors Picks

FREELANDER 8 Makes First Public Appearance Ahead of Official Abu Dhabi Launch

June 13, 2026

Hitch Open Ping-Pong Embodied (HOPE) AI Challenge Joins the 2026 World Humanoid Robot Games, Seeding Advanced Physical AI Against Human Performance

June 13, 2026

No Deposit Bonus Casino Real Money 2026 – BetOnline Offered No Deposit Bonuses

June 13, 2026

Rent Water Purifier in Chennai Instead of Buying in 2026: Rentomojo Highlights Rising AMC (Annual Maintenance Charges) Driving Shift to Rentals

June 12, 2026

Latest News

Defiance ETFs Announces Temporary Trading Halt of the Defiance Daily 2X Space ETF (SPCL) on Cboe BZX Exchange, Inc.

June 12, 2026

Looking for FIFA World Cup watch parties in Metro Vancouver? Here they are

June 12, 2026

Crypto News Today: AlphaPepe Unveils AlphaSwap Early Access as Bitcoin Price Prediction Eyes $250,000

June 12, 2026
Facebook X (Twitter) Pinterest TikTok Instagram
© 2026 Daily Guardian Canada. All Rights Reserved.
  • Privacy Policy
  • Terms
  • Advertise
  • Contact

Type above and press Enter to search. Press Esc to cancel.

Go to mobile version